[Product Description]
HA130 resin hemoperfusion
cartridge is of relatively specific
recognition and adsorption
capacity to the macromolecular
uremic toxins resulting from long-
term hemodialysis and
hemofiltration in blood of end-
stage renal disease (ESRD) patients. In clinic, HD+HP
treatment by association of
hemodialysis (HD) &
hemoperfusion (HP) could clear
various uremic toxins in ESRD
patients, decrease morbidity of
complications in long-term and
short-term, prolong life span and
improve life quality. The product
is hereinafter named as
hemoperfusion cartridge for
short.
HA130 resin hemoperfusion
cartridge is of relatively specific
recognition and adsorption
capacity to the macromolecular
uremic toxins in blood of (ESRD) patients.
Application of patients: the
product is applicable to
hemodialysis patients, and
HP+HD joint treatment which
could prevent and improve long-
term hemodialysis complications
such as renal osteopathy, refractory skin pruritus, peripheral neuropathy
Statistics: Companies: 641,400+, Trade Leads: 160,300+, Products: 104,200+, Contacts / Replies: 8,283,400+ There are currently 41772 users online browsing our B2B network. 1:56 GMT, Sunday, December 1, 2024 Privacy Policy Important Notice! TradeHolding.com B2B Network does not provide an escrow service! Any member who asks you to pay for their products by Western Union to an agent of "TradeHolding.com B2B Network" is fraud and should be immediately reported to us. Do not pay anything to any member who states your money will be added to TradeHolding.com safety deposit account!
All Trade Leads / Offers / Products / Company Profiles / Images and other user-posted contents are posted by the user and BR.TradeHolding.com and TradeHolding.com B2B Network shall not be held liable for any such content. However, TradeHolding.com B2B Network respects the intellectual property, copyright, trademark, trade secret or any other personal or proprietary third party rights and expects the same from others. For concerns, please contact us.